Recent Updates
Recently added Catalysts
PEN Positive Sentiment Score: 70/100

Penumbra, Inc. to Present at the Wells Fargo Healthcare Conference Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Wells Fargo Healthcare Conference on Wednesday,...

Wednesday, August 21, 2024 1 min read
Key Takeaway: Penumbra, Inc. is set to present at the Wells Fargo Healthcare Conference on September 4, 2024. This engagement reflects the company's ongoing commitment to sharing advancements in thrombectomy technology. Attendees will have the opportunity to access the presentation via a webcast available on Penumbra's website. The company emphasizes its role in addressing critical medical conditions and improving patient care globally.

Market Sentiment Analysis

POSITIVE FACTORS

  • Penumbra will showcase its innovations at a prestigious conference.
  • The company's leadership is engaging with investors and stakeholders.
  • Penumbra's technologies focus on significant medical conditions, highlighting their commitment to improving patient outcomes.

Full Press Release Details

ALAMEDA, Calif. , Aug. 21, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced that its management team is scheduled to present at the Wells Fargo Healthcare Conference on Wednesday, September 4, 2024 .
Event: Wells Fargo Healthcare Conference
Date: Wednesday, September 4, 2024
Time: 2:15pm ET/11:15am PT
A webcast of the presentation can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com . The webcast will be available on the company's website for at least two weeks following the event.
About Penumbra Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit www.penumbrainc.com and connect on Instagram , LinkedIn and X .
Investor Relations Penumbra, Inc. [email protected]
SOURCE Penumbra, Inc.

21 %

Frequently Asked Questions

When is the Wells Fargo Healthcare Conference presentation?

The conference presentation is on September 4, 2024, at 2:15 PM ET.

How can I access the presentation webcast?

The webcast can be accessed on the company's website under the 'Investors' tab.

How long will the webcast be available?

The webcast will be available for at least two weeks after the event.

What is the focus of Penumbra, Inc.?

Penumbra, Inc. specializes in thrombectomy technologies for severe medical conditions.

In how many countries does Penumbra operate?

Penumbra supports healthcare providers in over 100 countries globally.

Tags: PEN Viatris Investor Conferences Healthcare Penumbra Wells Fargo thrombectomy healthcare conference medical technology
Last updated: Aug 21, 2024